An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

American Behavioral Clinics (ABC) is proud to announce the launch of SPRAVATO® (esketamine) treatment at its Oak Creek clinic. OAK CREEK, WI, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- American ...

Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...